Joseph Jankovic

发表

[Table, GeneReview Scope].

Neepa Patel, Joseph Jankovic, 2016 .

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

Yu Wang, Douglas Galasko, Min Shi, 2011, Annals of neurology.

Genome-wide association study in essential tremor identifies three new loci

Dietrich Haubenberger, Mark Hallett, Günther Deuschl, 2016, Brain : a journal of neurology.

Symptomatic treatment of Huntington disease

Joseph Jankovic, J. Jankovic, Octavian R. Adam, 2008, Neurotherapeutics.

A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

Werner Poewe, Fabrizio Stocchi, Anthony Lang, 2009, The New England journal of medicine.

Effects of green tea polyphenols on dopamine uptake and on MPP+ -induced dopamine neuron injury.

Tianhong Pan, Jian Fei, Joseph Jankovic, 2003, Life sciences.

Genetics of essential tremor.

Hao Deng, Joseph Jankovic, J. Jankovic, 2007, Brain : a journal of neurology.

Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson’s disease

Joseph Jankovic, J. Jankovic, James K Sheffield, 2007, Expert review of neurotherapeutics.

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

Yan Liu, Dana Waichunas, Ali Samii, 2006, Journal of Alzheimer's disease : JAD.

The many faces of hemifacial spasm: Differential diagnosis of unilateral facial spasms

Joseph Jankovic, J. Jankovic, Toby C. Yaltho, 2011, Movement disorders : official journal of the Movement Disorder Society.

Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23.

Mark Hallett, John Hardy, Andrew B Singleton, 2006, Brain : a journal of neurology.

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson’s Disease

Mark Stacy, Joseph Jankovic, J. Jankovic, 2007, CNS drugs.

Dopaminergic Properties and Experimental Anti-Parkinsonian Effects of IPX750 in Rodent Models of Parkinson Disease

Joseph Jankovic, J. Jankovic, H. Niznik, 2004, Clinical neuropharmacology.

Clinical gait and balance scale (GABS): validation and utilization

Joseph Jankovic, J. Jankovic, E. Protas, 2004, Journal of the Neurological Sciences.

Clinical overview and phenomenology of movement disorders

Mark Hallett, Stanley Fahn, Joseph Jankovic, 2021, Principles and Practice of Movement Disorders.

Benefits and Risks of Pharmacological Treatments for Essential Tremor

William G. Ondo, Stanley Fahn, Rajesh Pahwa, 2003, Drug safety.

Clinimetric testing of the new UPDRS (MDS-UPDRS) vs. original version

Bruno Dubois, Andrew J. Lees, Jaime Kulisevsky, 2007 .

Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement

Tianhong Pan, Joseph Jankovic, J. Jankovic, 2008, Neurobiology of Disease.

Valproic acid‐mediated Hsp70 induction and anti‐apoptotic neuroprotection in SH‐SY5Y cells

Tianhong Pan, Joseph Jankovic, J. Jankovic, 2005, FEBS letters.

Neurodegenerative disease and iron storage in the brain

Joseph Jankovic, J. Jankovic, Madhavi Thomas, 2004, Current opinion in neurology.

Novel mutation in the TOR1A (DYT1) gene in atypical, early onset dystonia and polymorphisms in dystonia and early onset parkinsonism

Christine Klein, Peter P. Pramstaller, Thomas Gasser, 2001, Neurogenetics.

Gait disorders.

Joseph Jankovic, J. Jankovic, Joseph Jankovic, 2015, Neurologic clinics.

Head injury and posttraumatic movement disorders.

Joseph Jankovic, J. Jankovic, J. Krauss, 2002, Neurosurgery.

Mutations in NR4A2 associated with familial Parkinson disease

Hong Jiang, Joseph Jankovic, Pingyi Xu, 2003, Nature Genetics.

Nonlinear temporal organization of neuronal discharge in the basal ganglia of Parkinson's disease patients

Olivier Darbin, Jongil Lim, Joseph Jankovic, 2010, Experimental Neurology.

Basic and therapeutic aspects of neurotonins

Joseph Jankovic, Dirk Dressler, Hans Bigalke, 2004 .

New version of the UPDRS: Development methods and working document for field testing

Bruno Dubois, Andrew J. Lees, Jaime Kulisevsky, 2005 .

Tetrabenazine Treatment for Huntington's Disease-Associated Chorea

Joseph Jankovic, J. Jankovic, W. Ondo, 2002, Clinical neuropharmacology.

The relationship between essential tremor and Parkinson's disease.

Joseph Jankovic, J. Jankovic, M. A. Thenganatt, 2016, Parkinsonism & related disorders.

Mouse bioassay versus Western blot assay for botulinurn toxin antibodies Correlation with clinical response

Joseph Jankovic, J. Jankovic, Philip A. Hanna, 1998, Neurology.

Reliability of a new scale for essential tremor

Mark Hallett, Stanley Fahn, Rajesh Pahwa, 2012, Movement disorders : official journal of the Movement Disorder Society.

A case-controlled MRI/MRA study of neurovascular contact in hemifacial spasm.

Joseph Jankovic, Ling-Ling Chan, Eng-King Tan, 2000, Neurology.

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases.

Jing Zhang, John G Nutt, Joseph Jankovic, 2008, American journal of clinical pathology.

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy

N. P. Quinn, Joseph Jankovic, C. J. Mathias, 1996, Neurology.

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

John Seibyl, Mark Stacy, Stanley Fahn, 2004, Archives of neurology.

Neurohistopathological Findings at the Electrode–Tissue Interface in Long‐Term Deep Brain Stimulation: Systematic Literature Review, Case Report, and Assessment of Stimulation Threshold Safety

Joseph Jankovic, Suzanne Z Powell, J. Jankovic, 2014, Neuromodulation : journal of the International Neuromodulation Society.

Myorhythmia: Phenomenology, etiology, and treatment

Joseph Jankovic, Francisco Cardoso, J. Jankovic, 2015, Movement disorders : official journal of the Movement Disorder Society.

Striatal deformities of the hand and foot in Parkinson's disease

Joseph Jankovic, J. Jankovic, Ron Tintner, 2005, The Lancet Neurology.

Treatment of Dystonia

Joseph Jankovic, J. Jankovic, M. A. Thenganatt, 2013, Neurotherapeutics.

Long‐term deep brain stimulation for essential tremor: 12‐year clinicopathologic follow‐up

Joseph Jankovic, J. Jankovic, S. Powell, 2010, Movement disorders : official journal of the Movement Disorder Society.

Occupation and risk of parkinsonism: a multicenter case-control study.

Connie Marras, Kelly E Lyons, Joseph Jankovic, 2009, Archives of neurology.

Amplitude fluctuations in essential tremor.

Giovanni Mostile, Mario Zappia, Anthony Davidson, 2012, Parkinsonism & related disorders.

Mutation screening of the HTR2B gene in patients with Tourette syndrome

Hao Deng, Hongbo Xu, Xiong Deng, 2012, Neuroscience Letters.

Late‐onset Hallervorden‐Spatz disease presenting as familial parkinsonism

Philip J. Langlais, Joseph Jankovic, J. Jankovic, 1985, Neurology.

The future of research in Parkinson disease.

Todd Sherer, Joseph Jankovic, J. Jankovic, 2014, JAMA neurology.

Therapy with botulinum toxin

Mark Hallett, Joseph Jankovic, M. Hallett, 1994 .

Movement disorders in cerebrovascular disease

Joseph Jankovic, J. Jankovic, R. Mehanna, 2013, The Lancet Neurology.

The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond

Joohi Jimenez-Shahed, Joseph Jankovic, Robert Fekete, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Autopsy‐proven Huntington's disease with 29 trinucleotide repeats

Suzanne Powell, Joseph Jankovic, J. Jankovic, 2007, Movement disorders : official journal of the Movement Disorder Society.

Update on blepharospasm

Mark Hallett, Mark Stacy, Joseph Jankovic, 2008, Neurology.

Intrafamilial phenotypic variability of the DYT1 dystonia: From asymptomatic TOR1A gene carrier status to dystonic storm

Laurie Ozelius, Joseph Jankovic, J. Jankovic, 2002, Movement disorders : official journal of the Movement Disorder Society.

Psychogenic Tremor: A Video Guide to Its Distinguishing Features

Joseph Jankovic, J. Jankovic, M. A. Thenganatt, 2014, Tremor and other hyperkinetic movements.

Pathophysiology and Clinical Assessment of Parkinsonian Symptoms and Signs

Joseph Jankovic, J. Jankovic, 2003 .

Secondary causes of paroxysmal dyskinesia.

Joseph Jankovic, J. Jankovic, J. Blakeley, 2002, Advances in neurology.

Metoclopramide, an Increasingly Recognized Cause of Tardive Dyskinesia

Anthony Davidson, Joseph Jankovic, J. Jankovic, 2008, Journal of clinical pharmacology.

Comprar Parkinson's Disease and Movement Disorders, 6ª Ed. | Joseph Jankovic | 9781608311767 | Lippincott Williams & Wilkins

Joseph Jankovic, J. Jankovic, E. Tolosa, 2015 .

Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.

Anthony Davidson, Joseph Jankovic, J. Jankovic, 2007, Journal of neurosurgery.

Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine

Subhashie Wijemanne, Joseph Jankovic, J. Jankovic, 2016, Headache.

The genetics of Parkinson disease

Peng Wang, Hao Deng, Joseph Jankovic, 2018, Ageing Research Reviews.

An Open-Label Pilot Study of Levetiracetam for Essential Tremor

Joseph Jankovic, J. Jankovic, W. Ondo, 2004, Clinical neuropharmacology.

Age at onset in two common neurodegenerative diseases is genetically controlled.

Rajesh Pahwa, Fengyu Zhang, Kristin K Nicodemus, 2002, American journal of human genetics.

Role of nitric oxide in rotenone‐induced nigro‐striatal injury

Joseph Jankovic, J. Jankovic, W. Le, 2003, Journal of neurochemistry.

Diagnosis and Management of Parkinson's Disease

Joseph Jankovic, J. Jankovic, A. Tarakad, 2017, Seminars in Neurology.

Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease.

Eden R Martin, Rajesh Pahwa, Clemens R Scherzer, 2003, Human molecular genetics.

LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease

Matthew J. Farrer, Owen A. Ross, Alexandra I. Soto-Ortolaza, 2010, neurogenetics.

Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial

Ron Alterman, Rajesh Pahwa, Gordon H Baltuch, 2012, The Lancet Neurology.

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Norbert Schuff, Arthur W. Toga, John Seibyl, 2018, Annals of clinical and translational neurology.

Potential Therapeutic Properties of Green Tea Polyphenols in Parkinson’s Disease

Tianhong Pan, Joseph Jankovic, J. Jankovic, 2003, Drugs & aging.

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.

Eden R Martin, Rajesh Pahwa, Fengyu Zhang, 2003, Archives of neurology.

Pathophysiology and clinical assessment

Joseph Jankovic, J. Jankovic, R. Mehanna, 2013 .

Safety of MRI in patients with implanted deep brain stimulation devices

Michael S. Okun, Michele Tagliati, Ioannis U. Isaias, 2009, NeuroImage.

Manual of Botulinum Toxin Therapy: Botulinum toxin in tic disorders and essential hand and head tremor

Joseph Jankovic, James K. Sheffield, 2009 .

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.

Tianhong Pan, Joseph Jankovic, J. Jankovic, 2008, Brain : a journal of neurology.

Are Parkinson disease patients protected from some but not all cancers?

Rivka Inzelberg, Joseph Jankovic, J. Jankovic, 2007, Neurology.

Motor fluctuations and dyskinesias in Parkinson's disease: Clinical manifestations

Joseph Jankovic, J. Jankovic, 2005, Movement disorders : official journal of the Movement Disorder Society.

Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Case report.

Joseph Jankovic, J. Jankovic, C. Kenney, 2007, Journal of neurosurgery.

Biological effects of pramipexole on dopaminergic neuron-associated genes: relevance to neuroprotection

Tianhong Pan, Joseph Jankovic, J. Jankovic, 2005, Neuroscience Letters.

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

John Seibyl, Anthony E. Lang, Stanley Fahn, 2000, JAMA.

An Update on Tardive Dyskinesia: From Phenomenology to Treatment

Olga Waln, Joseph Jankovic, J. Jankovic, 2013, Tremor and other hyperkinetic movements.

A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes

Werner Poewe, Fabrizio Stocchi, Olivier Rascol, 2011, The Lancet Neurology.

Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture

Benjamin D. Greenberg, Ying Wang, Naomi R. Wray, 2013, PLoS genetics.

The association between Parkinson's disease and melanoma

Tianhong Pan, Joseph Jankovic, J. Jankovic, 2011, International journal of cancer.

Treatment options for Parkinson's disease.

Joseph Jankovic, J. Jankovic, Ron Tintner, 2002 .

Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome

Jerrold L Vitek, Joseph Jankovic, J. Jankovic, 2006, Movement disorders : official journal of the Movement Disorder Society.

Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location

Elisabeth A. Wilde, Joseph Jankovic, Michele K. York, 2009, Journal of the Neurological Sciences.